JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v3i1.2202 jpsim.v3i1.2202 Review Article Burkholderia Cepacia Complex- Evolution and Spectrum Fatima Tazeen taz.fatima88@gmail.com * Shakoor Sadia National Institute of Cardiovascular Diseases Aga Khan University Hospital. Karachi, Pakistan *Correspondence: Tazeen Fatima (taz.fatima88@gmail.com) 15 03 2022 2022 3 1 3 6 12 12 2021 09 01 2022 Copyright © 2022 The Author(s) 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 1 Tseng SP, Tsai WC, Liang CY, Lin YS, Huang JW, Chang CY, Tyan YC, Lu PL. The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity. PLoS One 2014; 9(8):e104986. 2 Leitão JH, Sousa SA, Ferreira AS, Ramos CG, Silva IN, Moreira LM. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Applied Microbiol Biotechnol. 2010;87(1):31-40. 3 LiPuma JJ. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med. 2005; 11(6):528-33. 4 Jin Y, Zhou J, Zhou J, Hu M, Zhang Q, Kong N, Ren H, Liang L, Yue J. Genome-based classification of Burkholderia cepacia complex provides new insight into its taxonomic status. Biology Direct. 2020;15(1):1-4. 5 Bach E, Sant'Anna FH, Magrich dos Passos JF, Balsanelli E, de Baura VA, Pedrosa FO, et al. Detection of misidentifications of species from the Burkholderia cepacia complex and description of a new member, the soil bacterium Burkholderia catarinensis sp. Pathog Dis. 2017;75(6): 1-8. 6 Ong KS, Aw YK, Lee LH, Yule CM, Cheow YL, Lee SM. Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil. Front Microbiol. 2016; 7(12):2046. 7 Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries 2009; 3(04):273-7. 8 Van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, Snoeck J, Goossens H. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Cont Hospital Epidemiol. 1998; 19(2):112-3. 9 Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nature Reviews Microbiology. 2005; 3(2):144-56. 10 Ku NS, Han SH, Kim CO, Baek JH, Jeong SJ, Jin SJ, Choi JY, Song YG, Kim JM. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia. Scand J Infect Dis. 2011; 43(10):792-7. 11 Patra S, Bhat R, Lewis LE, Purakayastha J, Sivaramaraju VV, Mishra S..Burkholderia cepacia sepsis among neonates. Indian J Pediatr. 2014; 81(11):1233-6. 12 Chandrasekaran A, Subburaju N, Mustafa M, Putlibai S. Profile of neonatal sepsis due to Burkholderia cepacia complex. Indian Pediatr 2016; 53(4):1109-10 13 Abdallah M, Abdallah HA, Memish ZA. Burkholderia cepacia complex outbreaks among non-cystic fibrosis patients in the intensive care units: a review of adult and pediatric literature. Infez Med. 2018; 26(4):299-307. 14 Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB, Woods CW. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infection Control & Hospital Epidemiology. 2007; 28(8):951-8. 15 Lee JK. Two outbreaks of Burkholderia cepacia nosocomial infection in a neonatal intensive care unit. J Paediat Child Health. 2008; 44(1‐2):62-6. 16 Pope CE, Short P, Carter PE. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand. J Cyst Fibros. 2010; 9(6):442-6. 17 Gautam V, Ray P, Puri GD, Sharma K, Vandamme P, Madhup SK, et.al. Investigation of Burkholderia cepacia complex in septicemia patients in a tertiary care hospital, India. Nepal Med Coll J. 2009; 11(4):222-4. 18 Fatima T, Khan E, Nasir A, Alidina S, Malik F, Arif S, Irfan S, Qureshi SM, Shakoor S. Predominance of Genomovar I among Burkholderia cepacia Complex bacteremia in the Neonatal Population–a study from Karachi, Pakistan. Infect Dis J Pakistan. 2020;29(2):31-46. 19 Doit C, Loukil C, Simon AM, Ferroni A, Fontan JE, Bonacorsi S, et.al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J Clin Microbiol. 2004;42(5):2227-30 20 Shaban RZ, Sotomayor-Castillo C, Nahidi S, Li C, Macbeth D, Mitchell BG, Russo PL. Global burden, point sources, and outbreak management of healthcare-associated Burkholderia cepacia infections: An integrative review. Infect Control Hospital Epidemiol. 2020; 41(7):777-83. 21 Van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, Snoeck J, Goossens H. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hospital Epidemiol. 1998; 19(2):112-3. 22 Ghazal SS, Al-Mudaimeegh K, Al Fakihi EM, Asery AT. Outbreak of Burkholderia cepacia bacteremia in immunocompetent children caused by contaminated nebulized sulbutamol in Saudi Arabia. American journal of infection control. 2006 Aug 1; 34(6):394-8. 23 Song JE, Kwak YG, Um TH, Cho CR, Kim S, Park IS, Hwang JH, Kim N, Oh GB. Outbreak of Burkholderia cepacia pseudobacteraemia caused by intrinsically contaminated commercial 0.5% chlorhexidine solution in neonatal intensive care units. J Hospital Infect. 2018; 98(3):295-9. 24 Bhise SM, Rahangdale VA, Qazi MS. Burkholderia Cepacia an emerging cause of septicemia-an outbreak in a neonatal Intensive Care Unit from a tertiary care hospital of central India. IOSR J Dent Med Sci. 2013; 10(4):41-3. 25 Pegues CF, Pegues DA, Ford DS, Hibberd PL, Carson LA, Raine CM, Hooper DC. Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak. Epidemiology & Infection. 1996 Jun; 116(3):309-17. 26 Salah A, Al-Subol I, Hudna A, Alhaj A, Alqubaty AR, Farie W, Sulieman D, Alnadhari O, Alwajeeh T, Alobathani F, Almikhlafy A. Neonatal sepsis in Sana’a city, Yemen: a predominance of Burkholderia cepacia. BMC Infect Dis. 2021; 21(1):1-0. 27 Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB, Woods CW. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infect Control Hosp Epidemiol. 2007; 128(08):951-8. 28 Qamar S, Noman F, Shamim S, Nadeem A, Ansari N, Chohan N, Qureishi A.Investigation of Burkholderia cepacia outbreak in a neonatal intensive care unit. Infect Dis J Pak. 2010; 19(2):167-71 29 Paul LM, Hegde A, Pai T, Shetty S, Baliga S, Shenoy S. An outbreak of Burkholderia cepacia bacteremia in a neonatal intensive care unit. Indian J Pediat. 2016; 83(4):285-8. 30 Kotsanas D, Brett J, Kidd TJ, Stuart RL, Korman TM. Disinfection of Burkholderia cepacia complex from non-touch taps in a neonatal nursery. J Perin Med. 2008; 36(3):235-9. 31 Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE. Successful treatment of persistent Burkholderia cepacia complex bacteremia with ceftazidime-avibactam. Antimicrobial Agents Chemo. 2018; 62(4):e02213-17. 32 Liao CH, Chang HT, Lai CC, Huang YT, Hsu MS, Liu CY, Yang CJ, Hsueh PR. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit. Diagnost Microbiol Infect Dis. 2011; 70(2):260-6. 33 Jarvis WR, Highsmith AK, Allen JR, Haley RW. Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit. Pediatr Infect Dis. 1983; 2(3):203-8.